For some people, planning tomorrow is an ordinary part of life. For others, it can feel like an uncertain privilege. This is the tension behind Tomorrow, a stage production by Oteikwu Emmanuel Adah, popularly known as IdomaLion, which explores the experiences of people living with sickle cell disease.
The play follows four recent graduates standing at the beginning of adulthood. They share ambitions, joke with one another and celebrate their milestones. Their friendship takes a different turn when the reality of one person's sickle cell status comes into the open.
Its tagline, “Some people can plan tomorrow. Others pray to see it,” captures the uncertainty that can shape the lives of people living with the condition. But Adah's intention is not to present them solely through their health challenges. He wants audiences to consider how society's attitudes affect their relationships, opportunities and expectations for the future.
The idea has a personal history. Adah lost a close friend living with sickle cell disease when he was younger, an experience that stayed with him. About five or six years ago, he and filmmaker Ayodeji Ojo began exploring a documentary about the condition. They spoke with people living with sickle cell disease, whom Adah refers to as warriors, to understand their experiences. The project was eventually put on hold.
“We began speaking with warriors to gather lived experiences, but at the time, I don't think we had matured enough as storytellers to carry the weight of that reality,” he says.
In June 2026, the idea returned with renewed urgency. Adah approached the production's lead writer, Sonia Usiwo Uyouyou, with the premise. They developed it into the stage play that became Tomorrow. When he read the first draft, he found its emotional foundation compelling. His contribution was to develop the technical and physical theatre elements that would bring the story to the stage.
For Adah, the title carries a particular meaning for people living with sickle cell disease. “Tomorrow is promised to no one, but for a warrior, planning a future often feels like a daring act of defiance,” he says.
That uncertainty is often missing from public conversations about the condition. Discussions tend to focus on genotype compatibility, painful crises and medical complications. Adah believes this leaves out the psychological and social pressures that people living with sickle cell disease encounter in their everyday lives.
He points to the questions that can complicate romantic relationships: when to disclose one's status, how a prospective partner might respond and whether the condition will cause someone to be viewed as a burden. He also highlights the experience of encountering healthcare workers who dismiss or minimise a crisis, alongside the difficulties of accessing adequate medical care.
These experiences informed the production's approach. Adah says he wants Tomorrow to challenge the tendency to treat people living with sickle cell disease as fragile or incapable of making long-term plans.
“Warriors do not want condolences; they want love, equal opportunities, uncompromised dignity, and an end to the casual discrimination that boxes them into diagnoses,” he says.
The production's development also involved people living with the condition. A member of the core team is a sickle cell warrior whose experience and advocacy work helped guide the writing and rehearsals. The team also engaged with warriors and advocacy networks in Nigeria, the United Kingdom and the United States to understand the different social, emotional and healthcare challenges they face.
Adah says this helped the team move beyond medical information and consider the lives people build alongside their diagnosis. The characters in Tomorrow have ambitions, friendships, romantic interests and personal disagreements. Their health condition is part of their lives, but it does not define every aspect of who they are.
This approach continues a pattern in Adah's work. Through IdomaLion Creations, he has developed productions that examine difficult social issues, including child molestation, domestic and sexual violence, trauma, insecurity and communal breakdown.
His earlier productions include Apa (Scar), which explored child molestation, trauma and societal neglect, and Through the Rays, which examined insecurity, betrayal, communal disunity, greed and tribal divisions. Ordeal, a one-woman stage performance addressing domestic and sexual abuse, was another production that brought him together with Usiwo.
Their working relationship made her a natural choice to write Tomorrow. Adah describes her as a collaborator who can translate broad ideas into fully developed drama. Both are alumni of the Homevida masterclass, and their previous work together had established a creative understanding.
“Directing her words felt like a natural creative progression,” he says.
Although Adah has written and produced several of his previous productions, Tomorrow gave him another opportunity to develop as a director. He clarifies that his stage directorial debut was in March 2026 with Ordeal. Directing Tomorrow marked his Lagos Fringe Festival directorial debut.
He says directing another writer's work required him to approach the script differently from his own writing. When directing a story he has written, he already knows the characters' histories and motivations. With another writer's script, he had to examine the emotional connections between scenes, the pauses and the meaning beneath the dialogue.
The process also challenged some of his assumptions about sickle cell disease. Through the production, he says, he developed relationships with warriors in Nigeria and other countries, gaining a broader understanding of their experiences.
On stage, the story's four friends provide the foundation for its theatrical language. Adah wanted audiences to feel as though they were sharing a room with the characters rather than watching a performance from a distance. The actors were encouraged to move between humour, spontaneity, vulnerability and emotional restraint, allowing the friendships to develop before the central conflict emerges.

The production also uses physical theatre to express tensions that the characters may not communicate directly. Adah says the movement director and choreographer helped translate internal pain and psychological conflict into movement. Sound and lighting mark changes in the emotional atmosphere, while the minimalist set keeps attention on the characters and their relationships.
The production's demands extended beyond the rehearsal room. As both director and producer, Adah had to manage the creative process while seeking institutional support for its wider social impact.
He describes moving between rehearsals and meetings with corporate foundations, ministries and clinical partners. Among the initiatives he was pitching were a Student Access Fund and on-site high-performance liquid chromatography (HPLC) screening, a laboratory method used in the analysis of haemoglobin variants.
For Adah, the aim is to connect the story being told on stage with practical support for people living with sickle cell disease. But raising funds for social-impact theatre in Nigeria remains difficult.
“The duality of the director-producer role is always demanding,” he says. “But the moment I step back into the rehearsal room, the burden lifts.”
Tomorrow was staged at the Lagos Fringe Festival on November 7 and 8, 2026, at J. Randle Forum, Venue 2. For Adah, the festival provided an opportunity to take the production's conversation about sickle cell disease to a wider audience.
He sees the play as part of a broader direction for IdomaLion Creations, which he describes as an arts-in-health and social advocacy organisation. Its work, he says, is intended to connect dramatic storytelling with community engagement and health interventions.
The company plans to tour Tomorrow across institutions and secondary schools nationwide. Adah also intends to continue directing, developing productions around other social issues that he believes deserve greater public attention.
His immediate ambition is to take the play beyond its Lagos Fringe performances. But the larger question raised by Tomorrow remains relevant beyond the stage: how can people living with sickle cell disease make plans for their lives when society keeps treating their futures as uncertain?
For Adah, the answer begins with changing how people see them. The play asks audiences to recognise the friendships, ambitions and relationships that exist alongside the condition, and to consider the effect of their assumptions on the people living with it.



